Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Multi-CAR T Cell Therapy for Acute Myeloid Leukemia [Phase 1, Phase 2]
A multi-CAR T cell therapy is being studied in Phase 1/Phase 2 for acute myeloid leukemia; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) [Phase 2]
This is a Phase 2 screening trial (MYELOMATCH) sponsored by the National Cancer Institute to assign people with myeloid cancers to a treatme…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) [Phase 2]
Phase 2 clinical trial update for a study evaluating novel therapeutics in newly diagnosed high-risk acute myeloid leukemia; the trial is cu…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial) [Phase 2]
Phase 2 trial in younger patients with intermediate-risk acute myeloid leukemia compares cytarabine + daunorubicin with and without venetocl…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Universal 4SCAR7U Targeting CD7-positive Malignancies [Phase 1]
A Phase 1 trial evaluating Universal 4SCAR7U, a CD7-targeting therapy from Shenzhen Geno-Immune Medical Institute, is currently recruiting. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia [Phase 1]
This document reports a Phase I clinical trial evaluating PLM-102 in adults with relapsed or refractory acute myeloid leukemia, which is cur…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms [Phase 1, Phase 2]
The Phase 1/2 study evaluating the combination of ruxolitinib and CPX-351 in advanced phase myeloproliferative neoplasms was terminated, wit…
-
CLINICAL_TRIALS other · 2026-04-24Clinical Trial Update: Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes [Phase 1]
Phase 1 trial evaluating cirtuvivint alone and in combination with ASTX727 in patients with acute myeloid leukemia and myelodysplastic syndr…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 trial of magrolimab in combination with azacitidine and venetoclax for acute myeloid leukemia has been terminated, with results po…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study [Phase 2]
Describes a Phase 2 randomized clinical trial at MD Anderson Cancer Center evaluating monitoring, detoxification, and rebalancing of metals …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Bexmarilimab in combination with standard of care for hematologic malignancies is active but not recru…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study of BGB-11417 in Participants With Myeloid Malignancies [Phase 1, Phase 2]
BeiGene is testing BGB-11417 in Phase 1/2 trials for myeloid malignancies, including acute myeloid leukemia and myelodysplastic syndromes, w…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2]
Phase 2 trial update on epigenetic priming in newly diagnosed acute myeloid leukemia; the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: 8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial of 8-Chloroadenosine in combination with venetoclax for relapsed/refractory acute myeloid leukemia is currently suspended.
-
CLINICAL_TRIALS other · 2026-04-23Clinical Trial Update: A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 pediatric acute myeloid leukemia trial of venetoclax in combination with conventional chemotherapy is suspended.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of the TmBU Conditioning Regimen in high-risk or relapsed/refractory acute leuke…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Pilot Imaging Study of Leukemia [Phase 1]
Phase 1 pilot imaging study in leukemia is currently recruiting. Conditions listed include acute lymphoblastic leukemia, acute myeloid leuke…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Functionally Optimized CD33 CAR-T Cell Therapy Targeting Recurrent/Refractory Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical trial update describes a functionally optimized CD33 CAR-T cell therapy targeting recurrent/refractory acute myeloid leuk…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease [Phase 2]
A Phase 2 randomized trial at MD Anderson Cancer Center compares two GVHD prophylaxis regimens after allogeneic stem cell transplantation in…
-
CLINICAL_TRIALS other · 2026-04-23Clinical Trial Update: Study of SA+X in the Treatment of Newly Diagnosed AML [Phase 2]
A Phase 2 clinical trial evaluating SA+X for newly diagnosed acute myeloid leukemia is currently recruiting at Ruijin Hospital.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation [Phase 1]
Phase 1 clinical trial evaluating ruxolitinib with azacitidine maintenance for Acute Myeloid Leukemia patients undergoing reduced-intensity …
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia [Phase 1]
This update reports the completion of a Phase 1 study evaluating pevonedistat in combination with decitabine for high-risk acute myeloid leu…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Imetelstat Combinations in Relapsed AML [Phase 1]
Clinical trial update notes a Phase 1 study of imetelstat in combination regimens for relapsed acute myeloid leukemia, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy [Phase 1]
Phase 1 study evaluating talazoparib in combination with chemotherapy in relapsed pediatric acute myeloid leukemia to assess safety and prel…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial is evaluating tranexamic acid in patients with myelodysplastic syndromes and acute myeloid leukemia and is currentl…